您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Penicillin V-d5(potassium salt)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Penicillin V-d5(potassium salt)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Penicillin V-d5(potassium salt)图片
规格:98%
分子量:393.5
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx23254
CAS:2699607-22-0
分子式:C16H12D5N2O5S.K
分子量:393.5
溶解度:PBS (pH 7.2): 10 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Penicillin V-d5is intended for use as an internal standard for the quantification of penicillin V by GC- or LC-MS. Penicillin V is a β-lactam antibiotic that inhibits the growth of bacteria.1,2,3In vitro, penicillin V inhibits the growth of clinical isolates ofStreptococci(MICs = 0.004-0.008 mg/L) andC. difficile(MICs = 1 to >256 mg/L).1,2Penicillin V also inhibits growth ofS. aureus in vitro(MIC = 0.016 mg/L) andin vivoin a thigh model of infection in mice.3It inhibits the growth ofS. pyogenesin mice following one or two dose therapy with curative dose (CD50) values of 0.207 and 0.031 mg, respectively.4Penicillin V (100 mg/kg per day, p.o.) prevents experimental acute otitis media in rats when administered prior to infection by pneumococci.5Formulations containing penicillin V have been used to treat bacterial infections of the skin, throat, ear, mouth, and respiratory tract.


1.Kamme, C., and Petersson, A.C.In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin VScand. J. Infect. Dis.25(1)37-42(1993) 2.NorÉn, T., Alriksson, I., Akerlund, T., et al.In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in SwedenClin. Microbiol. Infect.16(8)1104-1110(2010) 3.Overbosch, D., Mattie, H., and Van Furth, R.Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillinBr. J. Clin. Pharmacol.19(5)657-668(1985) 4.Powell, H.M., and Culbertson, C.G.Effectiveness of phenoxymethyl penicillin V, and sodium penicillin G against hemolytic Streptococcus infection in white miceProc. Soc. Exp. Biol. Med.90(1)186-187(1955) 5.Hermansson, A., Prellner, K., and HellstrÖm, S.Prevention of experimental acute otitis media with penicillin VActa Otolaryngol.109(1-2)119-123(1990)